SIM
TMO icon

Stratos Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Stratos Investment Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.6M Buy
11,170
+1,075
+11% +$516K 0.2% 90
2026
Q1 		$4.96M Buy
10,095
+363
+4% +$197K 0.2% 94
2025
Q4 		$5.64M Buy
9,732
+84
+0.9% +$47.5K 0.23% 88
2025
Q3 		$4.68M Buy
9,648
+431
+5% +$201K 0.19% 91
2025
Q2 		$3.74M Buy
9,217
+461
+5% +$193K 0.17% 100
2025
Q1 		$4.36M Buy
8,756
+1,326
+18% +$718K 0.23% 85
2024
Q4 		$3.87M Sell
7,430
-306
-4% -$168K 0.23% 81
2024
Q3 		$4.79M Buy
7,736
+412
+6% +$244K 0.33% 70
2024
Q2 		$4.05M Buy
7,324
+471
+7% +$270K 0.34% 75
2024
Q1 		$3.98M Buy
6,853
+251
+4% +$141K 0.39% 68
2023
Q4 		$3.5M Buy
6,602
+604
+10% +$292K 0.41% 62
2023
Q3 		$3.04M Buy
5,998
+294
+5% +$157K 0.45% 60
2023
Q2 		$2.98M Buy
5,704
+5
+0.1% +$2.7K 0.46% 56
2023
Q1 		$3.28M Sell
5,699
-70
-1% -$39.5K 0.55% 54
2022
Q4 		$3.18M Buy
5,769
+157
+3% +$83.2K 0.57% 52
2022
Q3 		$2.85M Sell
5,612
-547
-9% -$306K 0.58% 49
2022
Q2 		$3.35M Buy
6,159
+50
+0.8% +$27.5K 0.63% 47
2022
Q1 		$3.61M Sell
6,109
-87
-1% -$50K 0.6% 51
2021
Q4 		$4.13M Sell
6,196
-283
-4% -$177K 0.65% 48
2021
Q3 		$3.7M Buy
6,479
+1,913
+42% +$1.05M 0.64% 48
2021
Q2 		$2.3M Buy
4,566
+294
+7% +$139K 0.63% 52
2021
Q1 		$1.95M Sell
4,272
-277
-6% -$132K 0.62% 52
2020
Q4 		$2.12M Buy
4,549
+316
+7% +$148K 0.67% 51
2020
Q3 		$1.87M Sell
4,233
-1,701
-29% -$703K 0.68% 46
2020
Q2 		$2.15M Buy
5,934
+268
+5% +$89.8K 0.91% 35
2020
Q1 		$1.61M Buy
5,666
+4,199
+286% +$1.32M 0.86% 36
2019
Q4 		$476K Buy
+1,467
New +$445K 0.22% 78

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Stratos Investment Management's TMO Position: Q2 2026 in Review

Stratos Investment Management increased its Thermo Fisher Scientific (TMO) stake by 11% in Q2 2026, buying an estimated $516K and bringing the position to 11,170 shares worth $5.6M. The position accounts for 0.2% of the portfolio, ranked #90.

Stratos Investment Management first reported a position in TMO in Q4 2019 and has held it in 27 quarters since. The position peaked at $5.64M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Stratos Investment Management held 11,170 shares of Thermo Fisher Scientific worth $5.6M as of Q2 2026.
  • Stratos Investment Management bought 1,075 Thermo Fisher Scientific shares in Q2 2026, an estimated $516K.
  • Thermo Fisher Scientific made up 0.2% of Stratos Investment Management's portfolio in Q2 2026, its #90 holding.
  • Stratos Investment Management first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 27 quarters since.
  • Stratos Investment Management's Thermo Fisher Scientific position peaked at $5.64M in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Stratos Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.